Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.36
-0.08 (-1.80%)
At close: Aug 14, 2025, 3:59 PM
4.27
-2.06%
After-hours: Aug 14, 2025, 04:26 PM EDT
-1.80% (1D)
| Bid | 4.25 |
| Market Cap | 269.27M |
| Revenue (ttm) | 159.49M |
| Net Income (ttm) | 6.15M |
| EPS (ttm) | 0.39 |
| PE Ratio (ttm) | 11.18 |
| Forward PE | -3.04 |
| Analyst | Hold |
| Ask | 4.71 |
| Volume | 323,625 |
| Avg. Volume (20D) | 450,856 |
| Open | 4.38 |
| Previous Close | 4.44 |
| Day's Range | 4.30 - 4.42 |
| 52-Week Range | 3.50 - 12.40 |
| Beta | 1.42 |
About GLUE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLUE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GLUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Monte Rosa Therapeutics has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Monte Rosa Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+93.87%
Monte Rosa Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
